Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
Price:
17.63 USD
0.46%
Market Closed
Updated:
May 15, 2024
P/E
Price to Earnings
Price to Earnings
-10 472.7
Current
-77.2
Median
23.9
Industry
Lower
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-10 472.7
Market Cap
/
4.2B
Net Income
-400k
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
|
4.2B USD | -10 472.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
180.9B USD | 32.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
136.3B USD | 68.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
123.5B USD | 36.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.1B USD | 26.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108B USD | 61.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.9B USD | 55.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.2B EUR | 39 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
377.3B CNY | 31 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 36.8 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
49.9B USD | 78 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
19.8
2-Years Forward
P/E
17.5
3-Years Forward
P/E
N/A
You don't have any saved screeners yet
